ACCEL Lite: Omecamtiv Mecarbil and EF in the GALACTIC-HF Trial

<p>In this interview, Michelle O’Donoghue, MD, FACC; John Teerlink, MD, FACC; and Jeffrey Hsu, MD, PhD, discuss the effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in the GALACTIC-HF trial. Like what you hear? Get 20 episodes a month with CME/MOC credit at <a href= "http://www.acc.org/ACCEL">www.acc.org/ACCEL</a>.</p>